According to research published by UCLA researchers, the quality of diagnostics staging using biopsy for bladder cancer patients is now directly related to the survival of those patients. This means that patients need quality care from the earliest moments of diagnosis, as those who do not have the ideal biopsies are more likely to die […]
Treating Prostate Cancer from PSA Screening Alone
Routine PSA screening programs of prostate cancer detection have been a source of debate for many years. While some argue that these screenings help reduce mortality rates, others warn that the negatives of treating men who do not need to be treated due to their PSA alone can outweigh the potential for reduced deaths. A […]
Genetics/Family History & Early Onset Prostate Cancer
Studies from the University of Michigan Comprehensive Cancer Center suggest that more younger men may be being diagnosed with the uncommon aggressive form of prostate cancer. The most common age for prostate cancer occurrence is between the ages of 60 and 90. Most of these so-called prostate cancers detected are the Gleason 6 (3+3) “cancers” and on both […]
Greater Results with Adding Bladder Cancer Treatments
Muscle-invasive bladder cancer is a difficult cancer to treat with a high mortality rate. A recent study published in the British Journal of Cancer indicates an option that may help doctors achieve better treatment with radiotherapy. The study, which was funded by the Medical Research Council and performed by a team at the University of Manchester, found […]
Dr. Vorstman Featured in the Sun Sentinel
Dr. Bert Vorstman was recently featured in the Sun Sentinel in regards to the popular prostate cancer treatment procedures using robotics. You can read the full article HERE